Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA)
- to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with with type 2 diabetes mellitus who are at high risk for these events
The primary endpoint was major adverse cardiovascular events (often called MACE), a combined measure of: Cardiovascular death Nonfatal heart attack Nonfatal stroke Over a median follow-up of about 3.5 years, semaglutide reduced the relative risk of these events by about 20% compared with placebo
We serve clients from Orlando FL, Winter Park FL, Maitland FL, Conway FL, Altamonte Springs FL, and the surrounding areas
Dose adjustment may be needed in patients with kidney disease, please consult your doctor
